Hideho Okada

Title: The Innovative Contributions of Hideho Okada

Introduction

Hideho Okada is a prominent inventor based in Mill Valley, CA (US). He has made significant contributions to the field of medical science, particularly in the treatment of glioblastomas. With a total of 7 patents to his name, Okada's work is at the forefront of innovative cancer therapies.

Latest Patents

Okada's latest patents include groundbreaking methods for treating EGFRvIII expressing glioblastomas. These methods involve administering a molecular circuit that is primed by EGFRvIII to induce therapeutics specific for antigens expressed by the glioblastoma. Additionally, he has developed methods for treating glioblastomas, including EGFRvIII negative variants, using a binding triggered transcriptional switch (BTTS) that targets priming antigens in glioblastoma multiforme (GBM). His patents also encompass nucleic acids, cells, expression cassettes, and kits for practicing these methods.

Career Highlights

Throughout his career, Okada has worked with esteemed institutions such as the University of California and Ono Pharmaceutical Co., Ltd. His research has significantly advanced the understanding and treatment of glioblastomas, making him a key figure in the field.

Collaborations

Okada has collaborated with notable colleagues, including Yafei Hou and Wendell A Lim. These partnerships have further enriched his research and contributed to the development of innovative therapeutic methods.

Conclusion

Hideho Okada's contributions to medical science, particularly in the treatment of glioblastomas, highlight his role as a leading inventor in the field. His innovative patents and collaborations continue to pave the way for advancements in cancer therapy.